Σύγκριση μεθόδων

	Σκορ Αξιολόγησης Νοητικής Κατάστασης (ΣΑΝΚ)	Εξέταση Γνωστικών Λειτουργιών Addenbrooke (ACE)
Πεδίο	Νευροψυχολογία	Νευροψυχολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1972	2000
Δημιουργός	H. Mark Hodkinson	Padasalai Mathuranath
Τύπος	Brief clinician-administered cognitive screening instrument	Clinician-administered comprehensive cognitive examination
Θεμελιώδης πηγή	Hodkinson, H. M. (1972). Evaluation of a mental test score for assessment of mental impairment in the elderly. Age and Ageing, 1(4), 233-238.	Mathuranath, P. S., Nestor, P. J., Berrios, G. E., Rakowicz, W., & Hodges, J. R. (2000). A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology, 55(11), 1613-1620.
Εναλλακτικές ονομασίες	AMT, AMT4, Abbreviated Mental Test Score	ACE, ACE-R, ACE-III, Addenbrooke Cognitive Examination
Συναφείς	5	5
Σύνοψη	The Abbreviated Mental Test (AMT) is a brief, 10-item cognitive screening instrument developed by Hodkinson in 1972 and originally published in Age and Ageing. It was specifically designed to quickly assess cognitive function in older hospitalized patients, detecting delirium and dementia in acute hospital settings. The AMT is valued for its simplicity, brevity (2–3 minutes), and utility in fast-paced clinical environments where quick cognitive triage is essential.	The Addenbrooke's Cognitive Examination (ACE) is a brief yet comprehensive clinician-administered cognitive battery designed to assess multiple cognitive domains and differentiate between types of dementia. Originally developed by Mathuranath and colleagues at Cambridge University in 2000, the ACE was created to address limitations of single-domain screening tools. The revised version (ACE-R, 2006) and further refined version (ACE-III, 2013) provide updated norms and improved sensitivity. The ACE-R and ACE-III are particularly valuable for distinguishing Alzheimer's disease from frontotemporal dementia.